scispace - formally typeset
X

Xavier Benarous

Researcher at University of Picardie Jules Verne

Publications -  44
Citations -  511

Xavier Benarous is an academic researcher from University of Picardie Jules Verne. The author has contributed to research in topics: Medicine & Anxiety. The author has an hindex of 12, co-authored 27 publications receiving 339 citations. Previous affiliations of Xavier Benarous include Pierre-and-Marie-Curie University & King's College London.

Papers
More filters
Journal ArticleDOI

Ecological momentary assessment and smartphone application intervention in adolescents with substance use and comorbid severe psychiatric disorders: study protocol

TL;DR: This research aims to evaluate the feasibility of an ecological momentary assessment (EMA) intervention for all substance users, and of a smartphone application for cannabis users (Stop-Cannabis), for outpatient treatment after hospital discharge in adolescents with comorbid severe psychiatric disorders.
Journal ArticleDOI

Suicidal behaviors and irritability in children and adolescents: a systematic review of the nature and mechanisms of the association.

TL;DR: This review reviewed consistencies and variation in the literature linking irritability to suicidal ideation (SI) and suicide attempt (SA) and proposed specific mechanistic pathways, whereby irritability may modulate the risk for SB.
Journal ArticleDOI

Music Therapy for Children With Autistic Spectrum Disorder and/or Other Neurodevelopmental Disorders: A Systematic Review.

TL;DR: In this paper, the authors performed a systematic review according to the PRISMA guidelines to measure the effect of music interventions in children and adolescents with neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD).
Journal ArticleDOI

Adverse Childhood Experiences Among Inpatient Youths with Severe and Early-Onset Psychiatric Disorders: Prevalence and Clinical Correlates.

TL;DR: Youths who had been exposed to ACEs did not exhibit a more severe presentation or a poorer response to treatment compared to others, either in the bipolar group or in the catatonic group.